Ocata Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

OCAT 6.61 -0.11 (-1.64%)
price chart
The Butterfly Effect: Advanced Cell Technology Becomes Ocata Therapeutics ...
Ocata Therapeutics has entered an optimal moment in its developmental life cycle to initiate a long position. Prior to the as yet unknown date of up-list to the NASDAQ, which will occur with an accompanying equity raise, there is reason to believe the ...
Latest Updates on Ocata Therapeutics Inc (OTCMKTS:OCAT)  Equities Focus (registration)
Notable Movers - Dendreon (OTCMKTS:DNDNQ), Ocata Therapeutics ...  Street News Wire (press release)
Related articles »  
Advanced Cell Technology Changes Name to Ocata Therapeutics
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc., (OTCBB: OCAT) today announced the change of its company name to Ocata Therapeutics, Inc., effective immediately. The change, which has been approved by the Company's ...
Related articles »  
Should you place a bet on Ocata Therapeutics?
This brings us to Ocata Therapeutics. The company calls itself a "leader in regenerative medicine." What is that, and on what basis is Advanced Cell a leader in this field?
Related articles »  
Ocata Therapeutics to Present at 26 th Annual Piper Jaffray Health Care ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Ocata Therapeutics, Inc., (OTCBB: OCAT) today announced that Paul Wotton, Ph.D., President and Chief Executive Officer, will present a company overview at the 26th Annual Piper Jaffray Health Care ...
Related articles »  
Advanced Cell Technology Is Scaling Up Its Blood Program (ACTC)
What many people may not know is that same week the company published another unprecedented paper called: Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem Cells.
Related articles »  
Advanced Cell Technology's Turnaround Has Near-Term Catalysts (ACTC)
When Paul Wotton decided to leave a secure high paying CEO position at Antares Pharma to come aboard a financially strapped company with a history of bad financing decisions it was a turning point at ACT (soon to be known as Ocata Therapeutics).
Advanced Cell Technology Is Severely Undervalued (ACTC)
At the time this article was written, Advanced Cell Technology (OTCQB:ACTC) had a market cap of $220 million. For a typical pharmaceutical company with a few Phase I and several preclinical trials, this may seem to be quite a large valuation. But ACT ...
Advanced Cell Technology Annual Meeting Announcement: A Harbinger Of ...
Advanced Cell Technology (ACTC) has scheduled its annual meeting for 9 AM on November 12th. The most interesting points on the agenda are a name change for the company to Ocata Therapeutics, and a proposal to increase the number of authorized ...
Related articles »  
Penny Stocks Alert - Ocata Therapeutics (OCAT), GRUPO FINANCIERO ...
Ocata Therapeutics Inc (OTCMKTS:OCAT) proclaimed that its intention to offer and sell 10,000,000 shares of its common stock in an underwritten public offering pursuant to its existing shelf registration statement.
Ocata Therapeutics Inc. (ACTC) Stock to Watch
Ocata Therapeutics, Inc. (ACTC) has been moving in a bearish or rather dead trend since start of the year ,2014, but the stock did saw a major bullish rally in the month of September , 2014 when it touched its high of $11.73 at a trading volume of ...